Navigation Links
Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
Date:4/15/2009

EVRY, France, April 15 /PRNewswire/ -- Novagali Pharma, a French pharmaceutical ophthalmic company, today announces successful completion of a new Phase II clinical study with Cyclokat(R), its formulation of Cyclosporine. The results demonstrate statistically significant improvement with signs and symptoms in patients suffering from moderate-to-severe dry eye syndrome.

For this dry eye clinical trial, Novagali worked with Ora, Inc., a leading global clinical research and development organization located in Andover, MA, USA. This phase II, multi-centre, randomized, double-masked, vehicle controlled study of 132 patients evaluated the safety and efficacy of Cyclokat(R) applied once-a-day over three months. Ora's proprietary Controlled Adverse Environment (CAE) clinical model was used in this study conducted in the US.

Efficacy was observed post-CAE as well as pre-CAE (environmental comparisons following selection and enrollment of patients utilizing the CAE). Cyclokat(R) demonstrated significant treatment effect on multiple efficacy variables for both signs and symptoms at Month 1 and Month 3. . These findings confirm potential clinical interest of Cyclokat(R) for the treatment of dry eye syndrome.

"We are very enthusiastic about the results of this new trial demonstrating efficacy on both dry eye signs and symptoms" said Jerome Martinez, CEO of Novagali "These are promising results which make us confident in the success of our ongoing Phase III which outcomes are expected 4Q2009".

A pivotal Phase III trial is ongoing in Europe and patient recruitment has been already completed.

Cyclokat(R) is a proprietary ophthalmic emulsion enabling an optimal penetration of Cyclosporine in tissues of the eye surface that benefit from Novasorb(R), Novagali(R) cationic emulsion technology.

About Novagali Pharma : http:/
'/>"/>

SOURCE Novagali Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma
2. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
3. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
4. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
5. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
6. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
7. Strativa Pharmaceuticals Provides Product Pipeline Update
8. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
9. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
10. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 ... medications, yet only half of consumers surveyed are aware ... have ever used use them, according to findings from ... a community service partnership focused on improving the health ... The online survey polled 1,000 men and women, ages ...
(Date:8/3/2015)... --  The Intellectual Property and Science business of ... intelligent information for businesses and professionals announced the ... Factbook , the biopharmaceutical industry,s leading resource of ... R&D, the analysis identifies a surge in global ... sales to reach $1.3 trillion by 2018. It ...
(Date:8/3/2015)... , Aug. 3, 2015 Discovery Laboratories, ... company focused on developing aerosolized KL4 surfactant therapies ... and webcast at 8:30 a.m. Eastern Time on Tuesday ... discuss the 2015 second quarter financial results along ... issue a press release announcing the second quarter ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Pharma Sales to Grow Beyond $1 Trillion 2Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2
... 11 InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical ... it has completed enrollment of a 360 patient Phase ... of PPAR gamma (SPPARM) for the treatment of Type ... high dose active comparator (45mg Actos(R)) and placebo controlled ...
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... today announced that BioSpecifics, President, Tom Wegman, will present ... 29th Annual Health Care Conference on Tuesday, March 17, ... Place in Boston, MA. A live webcast of the ...
Cached Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Montclair State ... and Health, the first of its kind in New Jersey, which starting this Fall ... the Arts and Graduate School partnered with Atlantic Health System, one of the largest ...
(Date:8/4/2015)... ... August 04, 2015 , ... A new ... America IT reseller channel will grow at least 6 percent in 2015, as ... pace and greater than their OEM/vendor partners. , The 2112 Group’s 2015 ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... Process Chemistry and Scale-up Online Seminar featuring researchers from Lubrizol, Pfizer, and ... at 1:00 PM EDT. , Process development project timelines often require informed decisions ...
(Date:8/4/2015)... ... ... Catholic Health Partners) – a Catholic healthcare ministry serving Ohio and Kentucky – has devoted ... school athletes for fall sports. , In a concise video on Mercy Health’s YouTube ... What steps to take to help prevent injuries , How to see if ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... of 20 finalists for America’s Favorite Veterinarian. The contest is put on by ... judging committee from 500 nominees. Nominees were evaluated on community involvement, ethical behavior, ...
Breaking Medicine News(10 mins):Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:Mercy Health Video Provides Helpful Information for High School Athletes 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 3
... tendon may benefit from earlier surgical intervention and new surgical ... 2010 issue of the Journal of the American Academy ... the elbow, the distal biceps tendon attaches to the lower ... primary motions: , allowing the elbow to bend (elbow ...
... ... the Keynote Address at the HERS Foundation’s 28th Hysterectomy Conference, Saturday April 23rd at the ... ... Address at the HERS Foundation’s Hysterectomy Conference , Saturday April 23rd at the Hilton ...
... ... for the healthcare industry, today announced the addition of several new clients as well ... into the beginning of 2010. These sales agreements marked a recent period of growth ... solutions. , ...
... , WEDNESDAY, March 3 (HealthDay News) -- Food-borne illnesses ... year in health-related expenses, much more than previously thought, ... more than previous official estimates, and it demonstrates the ... Eskin, director of the Food Safety Campaign at the ...
... ... ... ... , ...
... ... ... ... ...
Cached Medicine News:Health News:Battling a biceps injury 2Health News:Battling a biceps injury 3Health News:Congresswoman Maloney To Be Keynote Speaker: Momentum Builds for Hysterectomy Informed Consent Legislation 2Health News:HealthcareSource Announces New Client Wins: Strong Sales Momentum Driven by Regional and Large Health Systems 2Health News:HealthcareSource Announces New Client Wins: Strong Sales Momentum Driven by Regional and Large Health Systems 3Health News:Food-borne Illnesses in U.S. Cost $152B Annually 2Health News:Food-borne Illnesses in U.S. Cost $152B Annually 3Health News:Labopharm to present at Cowen 30th Annual Health Care Conference 2Health News:NutraCea Announces Promotion of Leo G. Gingras to President 2Health News:NutraCea Announces Promotion of Leo G. Gingras to President 3Health News:NutraCea Announces Promotion of Leo G. Gingras to President 4Health News:NutraCea Announces Promotion of Leo G. Gingras to President 5
... The Patient Pak contains these ... bars (can be separated into ... two grounds. Single patient use ... wires (one twisted red and ...
... Keep yourself cool and your patient ... Bear personal cooling system.,Designed around the ... produce effective localized air flow around ... you cool during the heat and ...
... and large sizes, noise is not a ... disposable tabs. For use with mini-crocodile clip ... large tabs-2.2 x 2.5 cm (.875 x ... square. Each 100-count package contains 10 individually ...
... i-STAT Portable Clinical Analyzer (PCA) is ... for determination of a variety of ... stores up to 50 patient records ... results as well as transmission of ...
Medicine Products: